Latest news with #PhibroAnimalHealthCorporation
Yahoo
23-05-2025
- Business
- Yahoo
Best Growth Stocks to Buy for May 23rd
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, May 23rd: Phibro Animal Health Corporation PAHC: This animal health and mineral nutrition company carries a Zacks Rank #1 (Strong Buy), and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.6% over the last 60 days. Phibro Animal Health Corporation price-consensus-chart | Phibro Animal Health Corporation Quote Phibro has a PEG ratio of 0.45 compared with 1.30 for the industry. The company possesses a Growth Score of A. Phibro Animal Health Corporation peg-ratio-ttm | Phibro Animal Health Corporation Quote Great Lakes Dredge & Dock Corporation GLDD: This dredging services company carries a Zacks Rank #1 (Strong Buy), and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 34.8% over the last 60 days. Great Lakes Dredge & Dock Corporation price-consensus-chart | Great Lakes Dredge & Dock Corporation Quote Great Lakes Dredge & Dock has a PEG ratio of 0.98 compared with 1.59 for the industry. The company possesses aGrowth Scoreof A. Great Lakes Dredge & Dock Corporation peg-ratio-ttm | Great Lakes Dredge & Dock Corporation Quote Unisys Corporation UIS: These information technology solutions company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 132% over the last 60 days. Unisys Corporation price-consensus-chart | Unisys Corporation Quote Unisys has a PEG ratio of 0.57 compared with 2.43 for the industry. The company possesses a Growth Score of B. Unisys Corporation peg-ratio-ttm | Unisys Corporation Quote See the full list of top ranked stocks here. Learn more about the Growth score and how it is calculated here. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Unisys Corporation (UIS) : Free Stock Analysis Report Great Lakes Dredge & Dock Corporation (GLDD) : Free Stock Analysis Report Phibro Animal Health Corporation (PAHC) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
22-05-2025
- Business
- Business Wire
Phibro Animal Health Corporation to Participate at Stifel Jaws & Paws Conference
TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Stifel Jaws & Paws Conference. Chief Operating Officer, Larry Miller along with Director and Executive Vice President, Corporate Strategy, Daniel Bendheim will address financial analysts and investors on Thursday, May 29, 2025, at 8:35 AM ET at the Lotte New York Hotel in New York. The live audio presentation will be available on the Phibro Animal Health Corporation Investor Relations Website at A replay of the session will be available and archived on the company's website. About Phibro Animal Health Corporation Phibro Animal Health Corporation is a leading global diversified animal health and mineral nutrition company. We strive to be a trusted partner with livestock producers, farmers, veterinarians, and consumers who raise or care for farm and companion animals by providing solutions to help them maintain and enhance the health of their animals. For further information, please visit Our filings with the Securities and Exchange Commission are available online at or on request from the company.
Yahoo
15-05-2025
- Business
- Yahoo
Solid Earnings Reflect Phibro Animal Health's (NASDAQ:PAHC) Strength As A Business
Phibro Animal Health Corporation (NASDAQ:PAHC) recently posted some strong earnings, and the market responded positively. We did some digging and found some further encouraging factors that investors will like. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. Importantly, our data indicates that Phibro Animal Health's profit was reduced by US$22m, due to unusual items, over the last year. It's never great to see unusual items costing the company profits, but on the upside, things might improve sooner rather than later. We looked at thousands of listed companies and found that unusual items are very often one-off in nature. And, after all, that's exactly what the accounting terminology implies. If Phibro Animal Health doesn't see those unusual expenses repeat, then all else being equal we'd expect its profit to increase over the coming year. That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates. Unusual items (expenses) detracted from Phibro Animal Health's earnings over the last year, but we might see an improvement next year. Because of this, we think Phibro Animal Health's earnings potential is at least as good as it seems, and maybe even better! And on top of that, its earnings per share have grown at an extremely impressive rate over the last year. The goal of this article has been to assess how well we can rely on the statutory earnings to reflect the company's potential, but there is plenty more to consider. If you want to do dive deeper into Phibro Animal Health, you'd also look into what risks it is currently facing. Every company has risks, and we've spotted 2 warning signs for Phibro Animal Health (of which 1 is a bit concerning!) you should know about. Today we've zoomed in on a single data point to better understand the nature of Phibro Animal Health's profit. But there are plenty of other ways to inform your opinion of a company. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks with high insider ownership. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
Yahoo
14-05-2025
- Business
- Yahoo
Why Phibro Animal Health (PAHC) is a Top Value Stock for the Long-Term
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Achieving those goals is made easier with the Zacks Style Scores, a unique set of guidelines that rates stocks based on popular investing methodologies, namely value, growth, and momentum. The Style Scores can help you narrow down which stocks are better for your portfolio and which ones can beat the market over the long-term. Finding good stocks at good prices, and discovering which companies are trading under their true value, are what value investors like to focus on. So, the Value Style Score takes into account ratios like P/E, PEG, Price/Sales, and Price/Cash Flow to highlight the most attractive and discounted stocks. Headquartered in New Jersey, Phibro Animal Health Corporation is a leading global diversified animal health and mineral nutrition company. The company provides a broad range of products for food animals including poultry, swine, beef and dairy cattle and aquaculture. In addition to animal health and mineral nutrition products, Phibro manufactures and markets specific ingredients for use in the personal care, automotive, industrial chemical and chemical catalyst industries. At present, Phibro markets nearly 770 product lines in more than 80 countries to approximately 4,000 customers. PAHC is a Zacks Rank #2 (Buy) stock, with a Value Style Score of A and VGM Score of A. Shares are currently trading at a forward P/E of 12.2X for the current fiscal year compared to the Medical - Products industry's P/E of 18X. Additionally, PAHC has a PEG Ratio of 0.5 and a Price/Cash Flow ratio of 11.6X. Value investors should also note PAHC's Price/Sales ratio of 0.8X. Value investors don't just pay attention to a company's valuation ratios; positive earnings play a crucial role, too. Four analysts revised their earnings estimate upwards in the last 60 days for fiscal 2025. The Zacks Consensus Estimate has increased $0.07 to $2.01 per share. PAHC has an average earnings surprise of 30.6%. With strong valuation and earnings metrics, a good Zacks Rank, and top-tier Value and VGM Style Scores, investors should strongly think about adding PAHC to their portfolios. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Phibro Animal Health Corporation (PAHC) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
23-04-2025
- Business
- Business Wire
Phibro Animal Health Corporation to Host Webcast and Conference Call on Third Quarter Results
TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its third quarter financial results on Wednesday, May 7, 2025, after the market closes. Phibro management will host a conference call and webcast on Thursday, May 8, 2025, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conference call and view the presentation slides by visiting The discussion will also be available by dialing +1 (888) 330-2022 in the U.S. and Canada, or +1 (365) 977-0051 for international callers. Provide the conference ID 3927884. A replay of the webcast will be available approximately two hours after the conclusion of the live event. To access the webcast recording, visit About Phibro Animal Health Corporation Phibro Animal Health Corporation is a leading global diversified animal health and mineral nutrition company. We strive to be a trusted partner with livestock producers, farmers, veterinarians, and consumers who raise or care for farm and companion animals by providing solutions to help them maintain and enhance the health of their animals. For further information, please visit Our filings with the Securities and Exchange Commission are available online at or on request from the company.
